Trial Profile
Effects of 5HT2A Blockade in Depressed Patients with Inadequate Antidepressant Treatment Response
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2014
Price :
$35
*
At a glance
- Drugs Pruvanserin (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 30 Jun 2014 New trial record